about
Arginine deprivation therapy for malignant melanomaAsparaginase treatment side-effects may be due to genes with homopolymeric Asn codons (Review-Hypothesis)Components of cancer metabolism and therapeutic interventionsAcute pancreatitis in children and adolescentsAsparaginase pharmacokinetics and implications of therapeutic drug monitoringHow to manage asparaginase hypersensitivity in acute lymphoblastic leukemiaStructural and Kinetic Characterization of Guinea Pig l -Asparaginase Type IIICurrent applications and different approaches for microbial l-asparaginase productionPrimary Mitochondrial Disease and Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis and TreatmentMultiple adaptive mechanisms affect asparagine synthetase substrate availability in asparaginase-resistant MOLT-4 human leukaemia cellsPurification and characterization of a novel and robust L-asparaginase having low-glutaminase activity from Bacillus licheniformis: in vitro evaluation of anti-cancerous propertiesEngineering of Helicobacter pylori L-asparaginase: characterization of two functionally distinct groups of mutantsPurification and Characterization of Glutaminase Free Asparaginase from Enterobacter cloacae: In-Vitro Evaluation of Cytotoxic Potential against Human Myeloid Leukemia HL-60 CellsAmino acid deprivation using enzymes as a targeted therapy for cancer and viral infectionsRefolding and purification of recombinant L-asparaginase from inclusion bodies of E. coli into active tetrameric protein.Experimental Data in Support of a Direct Displacement Mechanism for Type I/II L-Asparaginases.Engineering thermal stability of L-asparaginase by in vitro directed evolution.Evaluation for inherited and acquired prothrombotic defects predisposing to symptomatic thromboembolism in children with acute lymphoblastic leukemia: a protocol for a prospective, observational, cohort study.Argininosuccinate synthase 1 is an intrinsic Akt repressor transactivated by p53Successful challenges using native E. coli asparaginase after hypersensitivity reactions to PEGylated E. coli asparaginaseThe clinical and cellular pharmacology of vincristine, corticosteroids, L-asparaginase, anthracyclines and cyclophosphamide in relation to childhood acute lymphoblastic leukaemia.Arginine starvation-associated atypical cellular death involves mitochondrial dysfunction, nuclear DNA leakage, and chromatin autophagy.Rationale for a pediatric-inspired approach in the adolescent and young adult population with acute lymphoblastic leukemia, with a focus on asparaginase treatment.Arginine starvation impairs mitochondrial respiratory function in ASS1-deficient breast cancer cells.Asparagine synthetase chemotherapy.Arginase treatment prevents the recovery of canine lymphoma and osteosarcoma cells resistant to the toxic effects of prolonged arginine deprivationFailure of amino acid homeostasis causes cell death following proteasome inhibition.Functional analysis of a novel DNA polymorphism of a tandem repeated sequence in the asparagine synthetase gene in acute lymphoblastic leukemia cells.Pegylated arginine deiminase: a novel anticancer enzyme agent.Drug monitoring of PEG-asparaginase treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma.Effect of premedications in a murine model of asparaginase hypersensitivityEnergy balance and fitness in adult survivors of childhood acute lymphoblastic leukemia.The best way to use asparaginase in childhood acute lymphatic leukaemia--still to be defined?Subgroups of Paediatric Acute Lymphoblastic Leukaemia Might Differ Significantly in Genetic Predisposition to Asparaginase HypersensitivityPolyethylene Glycol-conjugated L-asparaginase versus native L-asparaginase in combination with standard agents for children with acute lymphoblastic leukemia in second bone marrow relapse: a Children's Oncology Group Study (POG 8866).High incidence of symptomatic hyperammonemia in children with acute lymphoblastic leukemia receiving pegylated asparaginase.L-asparaginase-induced pancreatic injury is associated with an imbalance in plasma amino acid levels.Methanothermobacter thermautotrophicus tRNA Gln confines the amidotransferase GatCAB to asparaginyl-tRNA Asn formationEnhanced anti-tumour effects of Vinca alkaloids given separately from cytostatic therapies.Asparaginase-associated toxicity in children with acute lymphoblastic leukemia.
P2860
Q24634269-4D9A7A9D-0F48-4B85-AB22-2E628CE10997Q26801165-E25C75CE-C524-4DE1-B565-B3D6E9B418F7Q26823746-43DC0E55-33BC-4F29-BC0A-8F14C986BD25Q27008383-E4B9B86A-0389-4A3B-8898-0976B491916AQ27026476-8828D130-0EE2-46E3-9E7C-7869BA787C0FQ27026952-95402078-60CC-4F39-A469-3986368E4358Q27682506-1FD4F6D5-2B13-4B88-9873-1E751CA281A2Q28072068-477F0EF6-8DE6-48F7-AA66-139250041B77Q28078384-673128B0-D650-49A9-854A-B76149BB1049Q28345200-67FB2C4F-A0DC-4D00-9AED-31BD731DFD6DQ28539475-4BD3FFDF-D4D2-44DE-A094-1092138CFFB7Q28543369-D09003AA-098E-4867-8019-4A167EDC7E12Q28550260-791FE7F7-FE45-4A64-A01F-50DA2F647FE0Q30040775-FBD70C75-5E52-4F2E-9032-34D1D30D409BQ30367759-B3CBA557-3145-4F85-93D1-7B38A37897FAQ31035116-F35D2010-14EA-4039-8EC9-4ABAD84CF307Q33409731-B73D8AF6-321D-4A3D-A49F-2A228D08ADB2Q33640450-DEC3D66C-1207-41AB-B499-BD0057A21FB8Q33708112-FDB1F6F5-03FB-400A-B19D-C90027C3DBB8Q34064049-F01344E4-C2F2-4D5F-A2E7-77BC34F813AEQ34071686-674ECE32-2810-47A0-813F-F4F2C812A9DBQ34314481-C8687F6B-87AD-47B4-B800-CCC7B6D92937Q34325815-20AE9C95-A749-49F9-8C2D-BCAA00900EFAQ34497105-FF873D02-6083-4788-90CC-00F5AF9A5E1CQ34535185-CB430F1C-B6B1-49E3-A0C7-E342D2EF1D99Q34568337-739F923F-B249-47AE-9123-B7F69D37A01EQ34642317-AAAAA393-7FE7-4E15-B5A0-85AE3E1EDB7EQ34894425-B5635F42-EEE5-4E78-9C73-2BCA9B783EA9Q34911774-E93DB0B0-3BB8-4C48-8BA8-1463CFA88EC4Q35025684-B5A9A084-53A6-4C6E-A856-39D4B4F5CCA0Q35156439-C3627BA4-E9C2-404A-8D7C-14BFEA07E2FDQ35661991-F491E9FB-7ACD-4BF3-85F2-DA827C954CB2Q35732108-8BFBD0C5-CF98-431D-A305-A5BC3F3EDDB9Q35803355-CD702C99-BADC-4F98-9113-872752321A47Q36570330-4A7BD86E-7C48-4A93-931B-524500F1FDCFQ36617415-61A1904F-7ED2-41F6-9A43-E3FB9DC96351Q36649984-58AF0881-4207-4574-99C6-9EC3188E4A67Q36666608-98833249-2924-4E3D-ABDD-C20C6592DBB8Q36709220-12B0936C-024E-4F72-ADB1-86E3C3CFC947Q36762608-495826A9-95F0-43B0-A231-CBA2C3D969E0
P2860
description
1998 nî lūn-bûn
@nan
1998 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Use of ?-asparaginase in childhood ALL
@ast
Use of ?-asparaginase in childhood ALL
@en
type
label
Use of ?-asparaginase in childhood ALL
@ast
Use of ?-asparaginase in childhood ALL
@en
prefLabel
Use of ?-asparaginase in childhood ALL
@ast
Use of ?-asparaginase in childhood ALL
@en
P3181
P1476
Use of ?-asparaginase in childhood ALL
@en
P2093
P304
P3181
P356
10.1016/S1040-8428(98)00015-8
P577
1998-08-01T00:00:00Z